Clinical Trial Update: Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing FOLFOX4 plus panitumumab versus FOLFIRI plus panitumumab in KRAS wild-type colorectal cancer with liver-only metastases; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED